12-131960807-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_ModerateBP6_ModerateBS2
The NM_015409.5(EP400):āc.188A>Gā(p.Asn63Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000093 in 1,613,388 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_015409.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EP400 | NM_015409.5 | c.188A>G | p.Asn63Ser | missense_variant | 2/53 | ENST00000389561.7 | NP_056224.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EP400 | ENST00000389561.7 | c.188A>G | p.Asn63Ser | missense_variant | 2/53 | 5 | NM_015409.5 | ENSP00000374212 | P1 | |
EP400 | ENST00000333577.8 | c.188A>G | p.Asn63Ser | missense_variant | 2/13 | 1 | ENSP00000333602 | |||
EP400 | ENST00000332482.8 | c.188A>G | p.Asn63Ser | missense_variant | 2/8 | 1 | ENSP00000331737 | |||
EP400 | ENST00000703283.1 | c.188A>G | p.Asn63Ser | missense_variant | 1/11 | ENSP00000515253 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151836Hom.: 0 Cov.: 28
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250748Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135768
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461552Hom.: 0 Cov.: 36 AF XY: 0.00000688 AC XY: 5AN XY: 727086
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151836Hom.: 0 Cov.: 28 AF XY: 0.0000270 AC XY: 2AN XY: 74132
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at